Folic acid-conjugated graphene oxide as a transporter of chemotherapeutic drug and siRNA for reversal of cancer drug resistance

Journal of Nanoparticle Research

Volumn 15, Issue 10, 2013, Pages

  Cao, Xiufen ^a   Feng, Fuli ^a   Wang, Yinsong ^a   Yang, Xiaoying ^a   Duan, Hongquan ^a   Chen, Yongshen ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Anti cancer drug; Folic acid; Graphene oxide; Multidrug resistance; siRNA

Indexed keywords

CELLS; CHITOSAN; CHLORINE COMPOUNDS; CYTOLOGY; DISEASES; EFFICIENCY; GRAPHENE; GRAPHENE OXIDE; OLIGOSACCHARIDES; ORGANIC ACIDS; TARGETED DRUG DELIVERY;

ANTICANCER DRUG; CHITOSAN OLIGOSACCHARIDE; FOLIC ACIDS; FUNCTIONALIZED GRAPHENE; MCF-7 HUMAN BREAST CANCER CELLS; MULTIDRUG RESISTANCE; QUATERNARY AMMONIUM GROUP; SIRNA;

CONTROLLED DRUG DELIVERY;

CHITOSAN; DOXORUBICIN; FLUORESCEIN; FOLATE RECEPTOR; FOLIC ACID; GRAPHENE OXIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; OLIGOSACCHARIDE; SMALL INTERFERING RNA;

ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DRUG CONJUGATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALIGNANT NEOPLASTIC DISEASE; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERMOGRAVIMETRY; ZETA POTENTIAL;

EID: 84883145246     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1965-y     Document Type: Article

References (18)

1. Ambudkar S, Dey S, Hrycyna C, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398. doi: 10.1146/annurev. pharmtox.39.1.361 (Pubitemid 29222564)
2. Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, Li J, Gan LH (2011) Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7(11):1569-1578. doi: 10.1002/smll.201100191
3. Becerril HA, Mao J, Liu Z, Stoltenberg RM, Bao Z, Chen Y (2008) Evaluation of solution-processed reduced graphene oxide films as transparent conductors. ACS Nano 2:463-470. doi: 10.1021/nn700375n
4. Feng LZ, Liu Z (2011) Graphene in biomedicine: opportunities and challenges. Nanomedicine 6:317-324. doi: 10.2217/NNM.10.158
5. Feng LZ, Zhang S, Liu Z (2011) Graphene based gene transfection. Nanoscale 3:1252-1257. doi: 10.1039/c0nr00680g
6. Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155-199 (Pubitemid 20291782)
7. Leamon CP, Low PS (2001) Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 6:44-51. doi: 10.1016/S1359-6446(00) 01594-4 (Pubitemid 32156966)
8. Li S, Huang L (1997) In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 4:891-900. doi: 10.1038/sj.gt.3300482 (Pubitemid 27437714)
9. Liu Z, Robinson JT, Sun X, Dai H (2008) PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130:10876-10877. doi: 10.1021/ja803688x
10. Mi-Kyung L, Soo-Kyung C, Woo-Jeong C, Jin-Ki K, Sung-Hee C, Adele K, Kwunchit O, Jeong-Sook P, Woong SA, Chong-Kook K (2005) The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 26:2147-2156. doi: 10.1016/j.biomaterials.2004.07.008 (Pubitemid 39575358)
11. Patutina OA, Mironova NL, Popova NA, Kaledin VI, Nikolin VP, Vlassov VV, Zenkova MA (2010) The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy. BMC Cancer 10:204-214. doi: 10.1186/1471-2407-10-204
12. Shukla S, Wu CP, Ambudkar SV (2008) Development of inhibitors of ATP-binding cassette drug transporters - present status and challenges. Expert Opin Drug Metab Toxicol 4:205-223. doi: 10.1517/17425255.4.2.205 (Pubitemid 351308418)
13. Sun X, Liu Z, Welsher K, Robinson JT, Goodwin A, Zaric S, Dai H (2008) Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 1:203-212. doi: 10.1007/s12274-008-8021-8
14. Wu H, Hait WN, Yang JM (2003) Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 63:1515-1519 (Pubitemid 36373637)
15. Yang XY, Wang YS, Huang X, Ma YF, Huang Y, Yang RC, Duan HQ, Chen YS (2011) Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem 21:3448-3454. doi: 10.1039/c0jm02494e
16. Yang XY, Niu GL, Cao XF, Wen YK, Xiang R, Duan HQ, Chen YS (2012) The preparation of functionalized graphene oxide for targeted intracellular delivery of siRNA. J Mater Chem 22:6649-6654. doi: 10.1039/c2jm14718a
17. Zhang LM, Xia JG, Zhao QH, Liu LW, Zhang ZJ (2010) Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6:537-544. doi: 10.1002/smll.200901680
18. Zhang LM, Lu ZX, Zhao QH, Huang J, Shen H, Zhang ZJ (2011) Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7:460-464. doi: 10.1002/smll.201001522